Running title: Discovery of a novel glucose metabolism in cancer.
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Suppl. Table 1 : Body weight (in grams) and serum glucose level (in mmol/l) in each study group at PET scan time (day 7) and after 14 days from tumor implantation Suppl. Fig. 1 : Scatterplot of glucose consumption over 24 hours (in microMol per million cells on X axis) and % FDG uptake over one hour per million cells (Y axis). The seven cell lines (4T1-black, CT26-white, Calu-1-green, MDA-MB231-red, LNCAP-gray, GI-LI-N-blue and LB24-yellow as models of murine breast carcinoma, murine colon cancer, human non small cell lung cancer, human triple negative breast cancer, human prostate cancer, human neuroblastoma and melanoma) were studied in triplicate and all 21 points are reported. The experiments confirmed the expected correlation between the two metabolic indexes in the absence of any treatment. . A ten centimeters long silica gel thin chromatography paper (Merk, Germany) was used. A small mark was placed on one end and a small drop of 18 F-FDG (1µL) was put on TLC strip. The TLC was put into a TLC developing jar containing developing solution (95:5 acetonitrile: water V/V). When the developing solution reached more than eight centimeters on the TLC strip, it was removed and dried. Thereafter, TLC scanning was started for results. Virtually no 18 F -was detectable under any condition (red arrows). Similarly, no acetylated products (AP, green arrows) could be observed while virtually the whole amount of radioactivity was detected in the FDG area. 
